Professor Adilia Warris
Professor (Clinical) (Deputy Centre Director MRC CMM)
A.Warris@exeter.ac.uk
7593
01392 727593
Geoffrey Pope 318
Geoffrey Pope Building, University of Exeter , Stocker Road, Exeter, EX4 4QD, UK
Overview
I am a professor in paediatric infectious diseases with a specific interest in medical mycology. I am co-director of the MRC Centre for Medical Mycology at the University of Exeter and a consultant in paediatric infectious diseases in Great Ormond Street Hospital, London.
My research profile has a strong translational focus and specific areas of interest include the host-fungus interaction in specific patient groups with an emphasis on Aspergillus species; the unique interaction of A. nidulans and the CGD host, Aspergillus infections in people with cystic fibrosis, the development of new management strategies for invasive fungal disease in children, the epidemiology of invasive fungal infections in children, and the pharmacology of antifungals in paediatrics.
I chair the European Paediatric Mycology Network (EPMyN) through which post-graduate courses in Paediatric Mycology are coordinated as well as multi-center European studies to obtain a better insight in the fungal and clinical epidemiology of fungal infections in neonates and children. I am leading the Fungal Infection Scientific Content Area within PENTA Child Health. I am the Chief Investigator of cASPerCF, one of the investigator-led studies in the conect4children (C4C) network funded by the EU. The cASPerCF study aims to describe the epidemiology of Aspergillus infections in childeren and young adults with cystic fibrosis and to validate a posaconazole dosing algorithm to treat those infections. Additional ongoing studies are focussing on the fungal and clinical epidemiology of invasive fungal diseases in neonates and children (EPMyN-EUROCANDY study), and paediatric antifungal stewardship (PASOAP study).
Qualifications
1994 MD, University of Groningen, the Netherlands
2004 PhD Medical Science, Radboud University Nijmegen, the Netherlands
2014 Fellow of the Royal College of Paediatrics and Child Health
2018 Fellow of the Academy of the European Council Medical Mycology
Career
2003 Paediatrician
2005-2012 Consultant Paediatric Infectious Diseases & Immunology, Radboud University Nijmegen, the Netherlands
2009 Visiting Research Fellow, National Institutes of Health, Bethesda, MD, US
2012-2013 Associate Professor Paediatric Infectious Diseases & Immunology, Radboud University Nijmegen, the Netherlands
2013 Clinical Reader Medical Mycology, University of Aberdeen, UK
2013-2019 Honorary Consultant Paediatric Infectious Diseases, Royal Aberdeen Children’s Hospital, UK
2015-2019 Personal Chair, University of Aberdeen, UK
2019 Consultant Paediatric Infectious Diseases, Great Ormond Street Hospital, London
Research
Research interests
My research is aimed at unravelling unique host-fungus interactions based on clinical observations.
Patients with chronic granulomatous disease (CGD), suffering from an inborn error in the function of white blood cells, have an extremely high-risk to develop invasive aspergillosis and often these infections are fatal. Invasive aspergillosis in patients with CGD is caused by 2 different Aspergillus species, Aspergillus fumigatus and Aspergillus nidulans, with the latter having a unique predilection for this specific patient group. Our studies are focussed on the molecular interaction between immune cells from CGD patients and those fungi, with the ultimate goal to find new targets to improve treatment. In addition we are researching how A. fumigatus can persist and adapt in the lungs of patients with CGD, leading to recurrent infections and the fungus becoming resistant to antifungal therapy.
Comparable studies are done with immune cells from people with cystic fibrosis (CF). Half of the people with CF will be infected with A. fumigatus in their lungs leading to exacerbation of lung disease. The pathophysiology of Aspergillus infections in people with CF is not well understood and next to the presence of the thick sticky mucus entrapping the fungal spores in the lungs of people with CF, their immune cells respond abnormally to the presence of A. fumigatus. By studying the interaction between CF immune cells and A. fumigatus we aim to increase our insight in this specific host-fungus interactions and to find new treatment modalities to preserve lung function.
Research Group:
dr Emily Chesshyre, clinical research fellow
dr Laura Ferreras-Antolin, clinical research fellow
Alex Currie, PhD student
Elliot Mahony, PhD student
dr Harshani Tabrew, visiting clinical fellow (Sri Lanka)
dr Naamal Jayawardena, visiting clinical fellow (Sri Lanka)
Research networks
Chief Investigator of the cASPerCF study, a connect4children proof-of-viability study (conect4children.org) funded by IMI-2 (Innovative Medicines Initiative 2).
Co-investigator of the Strategic Research Centre TrIFIC consortium (trific.org) funded by the UK CF Trust.
Lead of the Fungal Infection Working Group of Penta Child Health (penta-id.org)
Publications
Books
Tenbrink T, Stell J, Galton A, Wood Z (2013). Preface.
Warris A, De Groot R (2006). Human metapneumovirus: an important cause of acute respiratory illness.
Journal articles
Nooitgedagt JE, Warris A, Liem KDD, van t Hek L, Henriet SS (In Press). Kinkhoest bij jonge zuigelingen: een gevaarlijke ziekte met aspecifieke verschijnselen. Nederlands tijdschrift voor geneeskunde, 157 Abstract.
Gifford A, Jayawardena N, Carlesse F, Lizarazo J, McMullan B, Groll AH, Warris A (2024). Pediatric Cryptococcosis. Pediatr Infect Dis J, 43(4), 307-312. Abstract. Author URL.
Bradbury JD, Chesshyre E, Orenti A, Jung A, Warris A, European Cystic Fibrosis COVID project group (2023). A multinational report on SARS-COV-2 infection outcomes in people with CF and Aspergillus infection or ABPA. J Cyst Fibros Abstract. Author URL.
Cruciani M, White PL, Barnes RA, Loeffler J, Donnelly JP, Rogers TR, Heinz WJ, Warris A, Morton CO, Lengerova M, et al (2023). An Overview of Systematic Reviews of Polymerase Chain Reaction (PCR) for the Diagnosis of Invasive Aspergillosis in Immunocompromised People: a Report of the Fungal PCR Initiative (FPCRI)-An ISHAM Working Group. J Fungi (Basel), 9(10). Abstract. Author URL.
Pittet LF, Moore CL, McDonald E, Barry S, Bonten M, Campbell J, Croda J, Dalcolmo M, Davidson A, Douglas MW, et al (2023). Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial. eClinicalMedicine, 64, 102203-102203.
King J, Dambuza IM, Reid DM, Yuecel R, Brown GD, Warris A (2023). Detailed characterisation of invasive aspergillosis in a murine model of X-linked chronic granulomatous disease shows new insights in infections caused by Aspergillus fumigatus versus Aspergillus nidulans. Frontiers in Cellular and Infection Microbiology, 13
Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N, et al (2023). Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes and Endocrinology, 11(12), 905-914. Abstract.
Villanueva P, Crawford NW, Croda MG, Collopy S, Jardim BA, de Almeida Pinto Jardim T, Manning L, Lucas M, Marshall H, Prat-Aymerich C, et al (2023). Erratum: Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination. Heliyon, 9(6). Abstract. Author URL.
Villanueva P, Crawford NW, Croda MG, Collopy S, Jardim BA, de Almeida Pinto Jardim T, Manning L, Lucas M, Marshall H, Prat-Aymerich C, et al (2023). Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination. Heliyon, 9(4). Abstract. Author URL.
Ekeng BE, Itam-Eyo AE, Osaigbovo II, Warris A, Oladele RO, Bongomin F, Denning DW (2023). Gastrointestinal Histoplasmosis: a Descriptive Review, 2001–2021. Life, 13(3), 689-689. Abstract.
Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H, Abbott A, Abbott A, et al (2023). Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401(10387), 1499-1507. Abstract.
Terzić V, Levoyer L, Figarella M, Bigagli E, Mercier N, De Gastines L, Gibowski S, Trøseid M, Demotes J, Olsen IC, et al (2023). Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. Br J Clin Pharmacol, 89(4), 1318-1328. Abstract. Author URL.
Warris A (2023). Intro special issue MMCR session ISHAM. Medical Mycology Case Reports, 41
Ciesielski TH, Zhang X, Tacconelli A, Lutsar I, de Cabre VM, Roilides E, Ciccacci C, Borgiani P, Scott WK, Aboulker JP, et al (2023). Late-onset neonatal sepsis: genetic differences by sex and involvement of the NOTCH pathway. Pediatric Research, 93(4), 1085-1095. Abstract.
Cook A, Ferreras-Antolin L, Adhisivam B, Ballot D, Berkley JA, Bernaschi P, Carvalheiro CG, Chaikittisuk N, Chen Y, Chibabhai V, et al (2023). Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study. Med Mycol, 61(3). Abstract. Author URL.
Pittet LF, Messina NL, Orsini F, Moore CL, Abruzzo V, Barry S, Bonnici R, Bonten M, Campbell J, Croda J, et al (2023). Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers. N Engl J Med, 388(17), 1582-1596. Abstract. Author URL.
Villanueva P, Crawford NW, Croda MG, Collopy S, Jardim BA, Jardim TDAP, Marshall H, Prat-Aymerich C, Sawka A, Sharma K, et al (2023). Safety of BCG vaccination and revaccination in healthcare workers. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 19(2). Author URL.
Dambuza IM, Warris A, Salazar F (2023). Unmasking a fungal fire. PLOS Pathogens, 19(5), e1011355-e1011355. Abstract.
Takada S, Pico-Knijnenburg I, Pac M, Warris A, van der Burg M (2022). A Pitfall of Whole Exome Sequencing: Variants in the 5'UTR Splice Site of BTK Causing XLA. J Clin Immunol, 42(3), 709-712. Author URL.
Stevenson EM, Gaze WH, Gow NAR, Hart A, Schmidt W, Usher J, Warris A, Wilkinson H, Murray AK (2022). Antifungal Exposure and Resistance Development: Defining Minimal Selective Antifungal Concentrations and Testing Methodologies. Frontiers in Fungal Biology, 3
Warris A, Armstrong-James D (2022). Antifungal therapy for chronic pulmonary aspergillosis. Lancet Infect Dis, 22(7), 924-926. Author URL.
Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H, Abbott A, Abbott A, et al (2022). Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. The Lancet, 400(10349), 359-368. Abstract.
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N, Abdelaziz A, Abdelfattah M, et al (2022). Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399(10325), 665-676. Abstract.
Sandercock PAG, Darbyshire J, DeMets D, Fowler R, Lalloo DG, Munavvar M, Staplin N, Warris A, Wittes J, Emberson JR, et al (2022). Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19. Trials, 23(1). Abstract. Author URL.
Maertens J, Pagano L, Azoulay E, Warris A (2022). Liposomal amphotericin B-the present. J Antimicrob Chemother, 77(Suppl_2), ii11-ii20. Abstract. Author URL.
Bergeron A, Mikulska M, De Greef J, Bondeelle L, Franquet T, Herrmann JL, Lange C, Spriet I, Akova M, Donnelly JP, et al (2022). Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia. The Lancet Infectious Diseases, 22(12), e359-e369. Abstract.
Jayawardena-Thabrew H, Warris A, PASOAP Group, Ferreras-Antolin L (2022). Nystatin is commonly prescribed as prophylaxis in children beyond the neonatal age. Med Mycol, 61(1). Abstract. Author URL.
Messina NL, Germano S, McElroy R, Rudraraju R, Bonnici R, Pittet LF, Neeland MR, Nicholson S, Subbarao K, Curtis N, et al (2022). Off-target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19. Clinical and Translational Immunology, 11(4). Abstract.
Salazar F, Bignell E, Brown GD, Cook PC, Warris A (2022). Pathogenesis of Respiratory Viral and Fungal Coinfections. Clin Microbiol Rev, 35(1). Abstract. Author URL.
Ferreras-Antolín L, Irwin A, Atra A, Chapelle F, Drysdale SB, Emonts M, McMaster P, Paulus S, Patel S, Rompola M, et al (2022). Pediatric Antifungal Prescribing Patterns Identify Significant Opportunities to Rationalize Antifungal Use in Children. Pediatr Infect Dis J, 41(3), e69-e74. Abstract. Author URL.
Helmstetter N, Chybowska AD, Delaney C, Da Silva Dantas A, Gifford H, Wacker T, Munro C, Warris A, Jones B, Cuomo CA, et al (2022). Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targets. Genetics, 221(1). Abstract. Author URL.
Rhodes J, Abdolrasouli A, Dunne K, Sewell TR, Zhang Y, Ballard E, Brackin AP, van Rhijn N, Chown H, Tsitsopoulou A, et al (2022). Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment. Nat Microbiol, 7(5), 663-674. Abstract. Author URL.
Rhodes J, Abdolrasouli A, Dunne K, Sewell TR, Zhang Y, Ballard E, Brackin AP, van Rhijn N, Chown H, Tsitsopoulou A, et al (2022). Publisher Correction: Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment. Nat Microbiol, 7(11). Author URL.
Ekeng BE, Davies AA, Osaigbovo II, Warris A, Oladele RO, Denning DW (2022). Pulmonary and Extrapulmonary Manifestations of Fungal Infections Misdiagnosed as Tuberculosis: the Need for Prompt Diagnosis and Management. J Fungi (Basel), 8(5). Abstract. Author URL.
Wan M, Alessandrini E, Brogan P, Eleftheriou D, Warris A, Brüggemann R, Turner M (2022). Risk-proportionate approach to paediatric clinical trials: the legal requirements, challenges, and the way forward under the European Union Clinical Trials Regulation. Clin Trials, 19(5), 573-578. Abstract. Author URL.
Ferreras-Antolin L, Aziz N, Warris A (2022). Serial (1-3)-beta-D-Glucan (BDG) monitoring shows high variability among premature neonates. Med Mycol, 60(6). Abstract. Author URL.
Ferreras-Antolin L, Borman A, Diederichs A, Warris A, Lehrnbecher T (2022). Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Neonates, Children and Adolescents: a Critical Analysis of Current Data. Journal of Fungi, 8(12).
Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, Bromley M, Brüggemann R, Garber G, Cornely OA, et al (2022). Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol, 20(9), 557-571. Abstract. Author URL.
Cornely OA, Gow N, Hoenigl M, Warris A (2021). 10th Trends in Medical Mycology Held on 8 to 11 October 2021, Aberdeen, Scotland, Organized by the European Confederation of Medical Mycology (ECMM). Journal of Fungi, 7(11), 916-916. Abstract.
Chorafa E, Iosifidis E, Oletto A, Warris A, Castagnola E, Bruggemann R, Groll A, Lehrnbecher T, Ferreras-Antolin L, Mesini A, et al (2021). 1162. Antifungal Use in Immunocompromised Children in Europe: a 12-week Multicenter Modified Point prevalence Study (CALYPSO). Open Forum Infectious Diseases, 8(Supplement_1), s672-s673.
Groll AH, Pana D, Lanternier F, Mesini A, Ammann RA, Averbuch D, Castagnola E, Cesaro S, Engelhard D, Garcia-Vidal C, et al (2021). 8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation. Lancet Oncol, 22(6), e254-e269. Abstract. Author URL.
Lehrnbecher T, Averbuch D, Castagnola E, Cesaro S, Ammann RA, Garcia-Vidal C, Kanerva J, Lanternier F, Mesini A, Mikulska M, et al (2021). 8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation. Lancet Oncol, 22(6), e270-e280. Abstract. Author URL.
Zelante T, Choera T, Beauvais A, Fallarino F, Paolicelli G, Pieraccini G, Pieroni M, Galosi C, Beato C, De Luca A, et al (2021). Aspergillus fumigatus tryptophan metabolic route differently affects host immunity. Cell Rep, 34(4). Abstract. Author URL.
Lv Q, Elders BBLJ, Warris A, Caudri D, Ciet P, Tiddens HAWM (2021). Aspergillus-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?. Eur Respir Rev, 30(162). Abstract. Author URL.
Warris A, Schwartz I (2021). Editorial MMCR special issue 'Covid-19 associated pulmonary aspergillosis'. Med Mycol Case Rep, 31 Author URL.
Ferreras-Antolin L, Bielicki J, Warris A, Sharland M, Hsia Y, GARPEC Network (2021). Global Divergence of Antifungal Prescribing Patterns: Data from the Global Antimicrobial Resistance, Prescribing, and Efficacy in Neonates and Children Surveys. Pediatr Infect Dis J, 40(4), 327-332. Abstract. Author URL.
Hoenigl M, Salmanton-García J, Walsh TJ, Nucci M, Neoh CF, Jenks JD, Lackner M, Sprute R, Al-Hatmi AMS, Bassetti M, et al (2021). Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. Lancet Infect Dis, 21(8), e246-e257. Abstract. Author URL.
Warris A (2021). Macrolides (Alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: Myth or maxim?. Breathe, 17(3).
Hatinguais R, Pradhan A, Brown GD, Brown AJP, Warris A, Shekhova E (2021). Mitochondrial Reactive Oxygen Species Regulate Immune Responses of Macrophages to Aspergillus fumigatus. Front Immunol, 12 Abstract. Author URL.
Macinnes R, Warris A (2021). Paediatric histoplasmosis 2000–2019: a review of 83 cases. Journal of Fungi, 7(6). Abstract.
Cruciani M, White PL, Mengoli C, Löffler J, Morton CO, Klingspor L, Buchheidt D, Maertens J, Heinz WJ, Rogers TR, et al (2021). The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis. J Antimicrob Chemother, 76(3), 635-638. Abstract. Author URL.
Ballard E, Yucel R, Melchers WJG, Brown AJP, Verweij PE, Warris A (2020). Antifungal Activity of Antimicrobial Peptides and Proteins against Aspergillus fumigatus. J Fungi (Basel), 6(2). Abstract. Author URL.
Currie AJ, Main ET, Wilson HM, Armstrong-James D, Warris A (2020). CFTR Modulators Dampen Aspergillus-Induced Reactive Oxygen Species Production by Cystic Fibrosis Phagocytes. Frontiers in Cellular and Infection Microbiology, 10 Abstract.
Lehrnbecher T, Fisher BT, Phillips B, Beauchemin M, Carlesse F, Castagnola E, Duong N, Dupuis LL, Fioravantti V, Groll AH, et al (2020). Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients with Cancer and Hematopoietic Stem-Cell Transplantation Recipients. J Clin Oncol, 38(27), 3205-3216. Abstract. Author URL.
Warris A, Pana Z-D, Oletto A, Lundin R, Castagnola E, Lehrnbecher T, Groll AH, Roilides E, EUROCANDY Study Group (2020). Etiology and Outcome of Candidemia in Neonates and Children in Europe: an 11-year Multinational Retrospective Study. Pediatr Infect Dis J, 39(2), 114-120. Abstract. Author URL.
Lutsar I, Chazallon C, Trafojer U, de Cabre VM, Auriti C, Bertaina C, Calo Carducci FI, Canpolat FE, Esposito S, Fournier I, et al (2020). Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): a randomised controlled trial. PLoS One, 15(3). Abstract. Author URL.
Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, et al (2020). Revision and Update of the Consensus Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis, 71(6), 1367-1376. Abstract. Author URL.
Warris A, Bercusson A, Armstrong-James D (2019). Aspergillus colonization and antifungal immunity in cystic fibrosis patients. Med Mycol, 57(Supplement_2), S118-S126. Abstract. Author URL.
White PL, Barnes RA, Gorton R, Cruciani M, Loeffler J, Alanio A, Bialek R, Bretagne S, Buchheidt D, Serna MJB, et al (2019). Comment on: T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 74(2), 532-533. Author URL.
Akase IE, Olowoyo O, Oladele RO, Obiako RO, Warris A, Akanmu SA (2019). Cryptococcal meningitis after ART: Need for proper baseline evaluation in the era of 'Test & Treat'. Med Mycol Case Rep, 24, 58-60. Abstract. Author URL.
Warris A, Lehrnbecher T, Roilides E, Castagnola E, Brüggemann RJM, Groll AH (2019). ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children. Clin Microbiol Infect, 25(9), 1096-1113. Abstract. Author URL.
Warris A (2019). Immunopathology of Aspergillus Infections in Children with Chronic Granulomatous Disease and Cystic Fibrosis. Pediatr Infect Dis J, 38(5), e96-e98. Author URL.
Lempers VJ, Meuwese E, Mavinkurve-Groothuis AM, Henriet S, van der Sluis IM, Hanff LM, Warris A, Koch BCP, Brüggemann RJ (2019). Impact of dose adaptations following voriconazole therapeutic drug monitoring in pediatric patients. Med Mycol, 57(8), 937-943. Abstract. Author URL.
Ferreras-Antolín L, Sharland M, Warris A (2019). Management of Invasive Fungal Disease in Neonates and Children. Pediatr Infect Dis J, 38(6S Suppl 1), S2-S6. Abstract. Author URL.
Brown AJP, Gow NAR, Warris A, Brown GD (2019). Memory in Fungal Pathogens Promotes Immune Evasion, Colonisation, and Infection. Trends in Microbiology, 27(3), 219-230. Abstract.
Ferreras-Antolín L, Irwin A, Atra A, Dermirjian A, Drysdale SB, Emonts M, McMaster P, Paulus S, Patel S, Kinsey S, et al (2019). Neonatal Antifungal Consumption is Dominated by Prophylactic Use; Outcomes from the Pediatric Antifungal Stewardship: Optimizing Antifungal Prescription Study. Pediatr Infect Dis J, 38(12), 1219-1223. Abstract. Author URL.
Warris A, Ballou ER (2019). Oxidative responses and fungal infection biology. Seminars in Cell and Developmental Biology, 89, 34-46. Abstract.
Ballard E, Zoll J, Melchers WJG, Brown AJP, Warris A, Verweij PE (2019). Raw genome sequence data for 13 isogenic Aspergillus fumigatus strains isolated over a 2 year period from a patient with chronic granulomatous disease. Data Brief, 25 Abstract. Author URL.
Ballard E, Weber J, Melchers WJG, Tammireddy S, Whitfield PD, Brakhage AA, Brown AJP, Verweij PE, Warris A (2019). Recreation of in-host acquired single nucleotide polymorphisms by CRISPR-Cas9 reveals an uncharacterised gene playing a role in Aspergillus fumigatus azole resistance via a non-cyp51A mediated resistance mechanism. Fungal Genet Biol, 130, 98-106. Abstract. Author URL.
Brunel SF, Willment JA, Brown GD, Devereux G, Warris A (2018). Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity. ERS Monograph, 4(2). Abstract.
Warris A (2018). Candida auris, what do paediatricians need to know?. Archives of Disease in Childhood, 103(9), 891-894. Abstract.
Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, et al (2018). Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clinical Microbiology and Infection, 24, e1-e38. Abstract.
Bercusson A, Colley T, Shah A, Warris A, Armstrong-James D (2018). Ibrutinib blocks Btk-dependent NF-ĸB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis. Blood, 132(18), 1985-1988.
Ballard E, Melchers WJG, Zoll J, Brown AJP, Verweij PE, Warris A (2018). In-host microevolution of Aspergillus fumigatus: a phenotypic and genotypic analysis. Fungal Genetics and Biology, 113, 1-13. Abstract.
Lutsar I, Chazallon C, Trafojer U, Meiffredy de Cabre V, Auriti C, Bertaina C, Calo Carducci FI, Canpolat FE, Esposito S, Fournier I, et al (2018). Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): a randomised controlled trial. Abstract.
Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, et al (2018). Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms. Microb Cell, 5(7), 300-326. Abstract. Author URL.
An SQ, Warris A, Turner S (2018). Microbiome characteristics of induced sputum compared to bronchial fluid and upper airway samples. Pediatric Pulmonology, 53(7), 921-928. Abstract.
Warris A (2018). Special issue: Host–fungus interactions. Journal of Fungi, 4(1).
Gow NAR, Amin T, McArdle K, Brown AJP, Brown GD, Warris A, the WTSA-MMFI Consortium (2018). Strategic Research Funding: a Success Story for Medical Mycology. Trends in Microbiology, 26(10), 811-813. Abstract.
Brunel SF, Willment JA, Brown GD, Devereux G, Warris A (2017). 79 Excessive reactive oxygen species production by cystic fibrosis phagocytes against Aspergillus fumigatus is adversely associated with number of clinical exacerbations and lung function. Journal of Cystic Fibrosis, 16, s84-s85.
Seyedmousavi S, van der Lee HA, Verweij PE, Warris A (2017). Absent in vitro interaction between chloroquine and antifungals against Aspergillus fumigatus. Clinical Microbiology and Infection, 23(9), 679-681.
Pana ZD, Roilides E, Warris A, Groll AH, Zaoutis T (2017). Epidemiology of Invasive Fungal Disease in Children. Journal of the Pediatric Infectious Diseases Society, 6(1), S3-S11. Abstract.
Bastiaans DET, Immohr LI, Zeinstra GG, Strik-Albers R, Pein-Hackelbusch M, van der Flier M, de Haan AFJ, Boelens JJ, Lankester AC, Burger DM, et al (2017). In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir. British Journal of Clinical Pharmacology, 83(12), 2789-2797. Abstract.
Brunel SF, Bain JM, King J, Heung LJ, Kasahara S, Hohl TM, Warris A (2017). Live imaging of antifungal activity by human primary neutrophils and monocytes in response to A. fumigatus. Journal of Visualized Experiments, 2017(122). Abstract.
Naselli A, Bishop H, Walker S, Warris A (2017). Neutropenic acute acalculous cholecystitis (AAC) in a 12-year-old boy with T-acute lymphoblastic leukemia successfully managed with conservative treatment. Pediatric Hematology and Oncology, 34(1), 24-28. Abstract.
Curtis N, Pollard AJ, Finn A, Ramilo O, Dobson S, Warris A, van Rossum A (2017). Preface. Journal of Infection, 74
Warris A, Lehrnbecher T (2017). Progress in the Diagnosis of Invasive Fungal Disease in Children. Current Fungal Infection Reports, 11(2), 35-44. Abstract.
King J, Pana ZD, Lehrnbecher T, Steinbach WJ, Warris A (2017). Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children. Journal of the Pediatric Infectious Diseases Society, 6(1), S12-S21. Abstract.
Calley JL, Warris A (2017). Recognition and diagnosis of invasive fungal infections in neonates. Journal of Infection, 74, S108-S113. Abstract.
Bastiaans DET, Bartels-Wilmer CM, Colbers APH, Heijens CAW, Velthoven-Graafland K, Smeets OSNM, Vink N, Harbers VEM, Warris A, Burger DM, et al (2016). A new paediatric formulation of valaciclovir: Development and bioequivalence assessment. Archives of Disease in Childhood, 101(10), 971-972.
King J, Henriet SSV, Warris A (2016). Aspergillosis in chronic granulomatous disease. Journal of Fungi, 2(2). Abstract.
King J, Brunel SF, Warris A (2016). Aspergillus infections in cystic fibrosis. Journal of Infection, 72, S50-S55. Abstract.
Tak R, Semmekrot B, Warris A, Yntema JB, Stelma F, Neeleman C (2016). Bacterial Tracheitis and Septic Shock. Pediatric Infectious Disease Journal, 35(2), 226-227.
Henriet SSV, Van De Sande WWJ, Lee MJ, Simonetti E, Momany M, Verweij PE, Rijs AJMM, Ferwerda G, Sheppard DC, De Jonge MI, et al (2016). Decreased Cell Wall Galactosaminogalactan in Aspergillus nidulans Mediates Dysregulated Inflammation in the Chronic Granulomatous Disease Host. Journal of Interferon and Cytokine Research, 36(8), 488-498. Abstract.
Murray JE, Bicknell LS, Yigit G, Duker AL, van Kogelenberg M, Haghayegh S, Wieczorek D, Kayserili H, Albert MH, Wise CA, et al (2016). Extreme Growth Failure is a Common Presentation of Ligase IV Deficiency (vol 35, pg 76, 2014). HUMAN MUTATION, 37(9), 983-983. Author URL.
Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, Ouachee-Chardin M, Fouyssac F, Girisha KM, Etzioni A, et al (2016). Heterozygous <i>STAT1</i> gain-of-function mutations underlie an unexpectedly broad clinical phenotype. BLOOD, 127(25), 3154-3164. Author URL.
Curtis N, Pollard AJ, Finn A, Ramilo O, Dobson S, Warris A, van Rossum A (2016). Preface. Journal of Infection, 72
Warris A (2016). Prophylactic antibiotics should be used in children with repaired oesophageal atresia and tracheo-oesophageal fistula: the case against. Paediatric Respiratory Reviews, 18, 62-63.
Bielicki JA, Sharland M, Johnson AP, Henderson KL, Cromwell DA, Berger C, Esposito S, Danieli E, Tenconi R, Folgori L, et al (2016). Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: Application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data. Journal of Antimicrobial Chemotherapy, 71(3), 794-802. Abstract.
Bart IY, Mourits M, van Gent R, van Leuken MH, Hilbink M, Warris A, Wever PC, de Vries E (2016). Sputum Induction in Children is Feasible and Useful in a Bustling General Hospital Practice. Glob Pediatr Health, 3 Abstract. Author URL.
Warris A (2016). The European Paediatric Mycology Network (EPMyN): Towards a Better Understanding and Management of Fungal Infections in Children. Current Fungal Infection Reports, 10(1), 7-9. Abstract.
Agrawal S, Barnes R, Brüggemann RJ, Rautemaa-Richardson R, Warris A (2016). The role of the multidisciplinary team in antifungal stewardship. Journal of Antimicrobial Chemotherapy, 71, ii37-ii42. Abstract.
Rokx C, Gras L, van de Vijver DAMC, Verbon A, Rijnders BJA, Prins JM, Kuijpers TW, Scherpbier HJ, van der Meer JTM, Wit FWMN, et al (2016). Virological responses to lamivudine or emtricitabine when combined with tenofovir and a protease inhibitor in treatment-naïve HIV-1-infected patients in the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort. HIV Medicine, 17(8), 571-580. Abstract.
Bielicki JA, Lundin R, Sharland M (2015). Antibiotic Resistance Prevalence in Routine Bloodstream Isolates from Children’s Hospitals Varies Substantially from Adult Surveillance Data in Europe. Pediatric Infectious Disease Journal, 34(7), 734-741.
Bhatt JM, Bush A, van Gerven M, Nissenkorn A, Renke M, Yarlett L, Taylor M, Tonia T, Warris A, Zielen S, et al (2015). Ataxia telangiectasia: why should the ERS care?. Eur Respir J, 46(6), 1557-1560. Author URL.
Warris A (2015). Azole-resistant aspergillosis. Journal of Infection, 71(S1), S121-S125. Abstract.
(2015). Boosted Lopinavir– Versus Boosted Atazanavir–Containing Regimens and Immunologic, Virologic, and Clinical Outcomes: a Prospective Study of HIV-Infected Individuals in High-Income Countries. Clinical Infectious Diseases, 60(8), 1262-1268.
Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P, de Wit S, d´Arminio Monforte A, Furrer H, Pradier C, et al (2015). Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68(5), 568-577.
Gras L, de Wolf F, Smit C, Prins M, van der Meer JTM, Vanhommerig JW, Zwinderman AH, Schinkel J, Geskus RB (2015). Changes in HIV RNA and CD4 Cell Count After Acute HCV Infection in Chronically HIV-Infected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68(5), 536-542.
Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, et al (2015). Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study. The Lancet HIV, 2(8), e335-e343.
Cohen S, Van Bilsen WPH, Smit C, Fraaij PLA, Warris A, Kuijpers TW, Geelen SPM, Wolfs TFW, Scherpbier HJ, Van Rossum AMC, et al (2015). Country of birth does not influence long-term clinical, virologic, and immunological outcome of HIV-infected children living in the Netherlands: a cohort study comparing children born in the Netherlands with children born in Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes, 68(2), 178-185. Abstract.
Zoll J, Rahamat-Langendoen J, Ahout I, Jonge MID, Jans J, Huijnen MA, Ferwerda G, Warris A, Melchers WJG (2015). Direct multiplexed whole genome sequencing of respiratory tract samples reveals full viral genomic information. Journal of Clinical Virology, 66, 6-11. Abstract.
Bhatt JM, Bush A, van Gerven M, Nissenkorn A, Renke M, Yarlett L, Taylor M, Tonia T, Warris A, Zielen S, et al (2015). ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia. Eur Respir Rev, 24(138), 565-581. Abstract. Author URL.
Muilwijk EW, Lempers VJC, Burger DM, Warris A, Pickkers P, Aarnoutse RE, Brüggemann RJM (2015). Impact of special patient populations on the pharmacokinetics of echinocandins. Expert Review of Anti-Infective Therapy, 13(6), 799-815. Abstract.
Verweij PE, Ananda-Rajah M, Andes D, Arendrup MC, Brüggemann RJ, Chowdhary A, Cornely OA, Denning DW, Groll AH, Izumikawa K, et al (2015). International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. Drug Resistance Updates, 21-22, 30-40. Abstract.
Brand HK, Ahout IML, De Ridder D, Van Diepen A, Li Y, Zaalberg M, Andeweg A, Roeleveld N, De Groot R, Warris A, et al (2015). Olfactomedin 4 serves as a marker for disease severity in pediatric respiratory syncytial virus (RSV) infection. PLoS ONE, 10(7). Abstract.
Colbers A, Moltó J, Ivanovic J, Kabeya K, Hawkins D, Gingelmaier A, Taylor G, Weizsäcker K, Sadiq ST, Van der Ende M, et al (2015). Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women. Journal of Antimicrobial Chemotherapy, 70(2), 534-542. Abstract.
van der Linden JWM, Arendrup MC, Warris A, Lagrou K, Pelloux H, Hauser PM, Chryssanthou E, Mellado E, Kidd SE, Tortorano AM, et al (2015). Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerging Infectious Diseases, 21(6), 1041-1044. Abstract.
Zhang S, van Sighem A, Kesselring A, Gras L, Prins JM, Hassink E, Kauffmann R, Richter C, de Wolf F, Reiss P, et al (2015). Risk of non‐<scp>AIDS</scp>‐defining events among <scp>HIV</scp>‐infected patients not yet on antiretroviral therapy. HIV Medicine, 16(5), 265-272. Abstract.
Achhra AC, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, Smith CJ, d'Arminio Monforte A, Phillips A, Weber R, et al (2015). Short‐term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the <scp>D</scp>:<scp>A</scp>:<scp>D</scp> study. HIV Medicine, 17(4), 255-268. Abstract.
Lestner JM, Versporten A, Doerholt K, Warris A, Roilides E, Sharland M, Bielicki J, Goossens H (2015). Systemic antifungal prescribing in neonates and children: Outcomes from the antibiotic resistance and prescribing in european children (arpec) study. Antimicrobial Agents and Chemotherapy, 59(2), 782-789. Abstract.
Schatorjé EJH, Van Der Steeg H, Stelma F, Hebeda K, Warris A (2014). Borrelial lymphocytoma. Nederlands Tijdschrift voor Geneeskunde, 158(17). Abstract.
Gathmann B, Mahlaoui N, Gérard L, Oksenhendler E, Warnatz K, Schulze I, Kindle G, Kuijpers TW, van Beem RT, Guzman D, et al (2014). Clinical picture and treatment of 2212 patients with common variable immunodeficiency. Journal of Allergy and Clinical Immunology, 134(1), 116-126.e11.
Westra D, Kurvers RAJ, Van den Heuvel LP, Würzner R, Hoppenreijs EPAH, Van der Flier M, Van de Kar NCAJ, Warris A (2014). Compound heterozygous mutations in the C6 gene of a child with recurrent infections. Molecular Immunology, 58(2), 201-205. Abstract.
Kamara DA, Ryom L, Ross M, Kirk O, Reiss P, Morlat P, Moranne O, Fux CA, Mocroft A, Sabin C, et al (2014). Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study. BMC Nephrology, 15(1).
Murray JE, Bicknell LS, Yigit G, Duker AL, van Kogelenberg M, Haghayegh S, Wieczorek D, Kayserili H, Albert MH, Wise CA, et al (2014). Extreme Growth Failure is a Common Presentation of Ligase IV Deficiency. Human Mutation, 35(1), 76-85. Abstract.
Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, Roilides E, Styczynski J, Warris A, Lehrnbecher T, et al (2014). Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. The Lancet Oncology, 15(8). Abstract.
Rokx C, Fibriani A, van de Vijver DAMC, Verbon A, Schutten M, Gras L, Rijnders BJA, Prins JM, Kuijpers TW, Scherpbier HJ, et al (2014). Increased Virological Failure in Naive HIV-1-Infected Patients Taking Lamivudine Compared with Emtricitabine in Combination with Tenofovir and Efavirenz or Nevirapine in the Dutch Nationwide ATHENA Cohort. Clinical Infectious Diseases, 60(1), 143-153.
Petoumenos K, Reiss P, Ryom L, Rickenbach M, Sabin CA, El‐Sadr W, d'Arminio Monforte A, Phillips AN, De Wit S, Kirk O, et al (2014). Increased risk of cardiovascular disease (<scp>CVD</scp>) with age in <scp>HIV</scp>‐positive men: a comparison of the <scp>D</scp>:<scp>A</scp>:<scp>D CVD</scp> risk equation and general population <scp>CVD</scp> risk equations. HIV Medicine, 15(10), 595-603. Abstract.
Warris A, Henriet SSV (2014). Invasive fungal infections in the child with chronic granulomatous disease. Current Fungal Infection Reports, 8(1), 37-44. Abstract.
de Boer M, van Leeuwen K, Geissler J, Weemaes CM, van den Berg TK, Kuijpers TW, Warris A, Roos D (2014). Primary Immunodeficiency Caused by an Exonized Retroposed Gene Copy Inserted in the CYBB Gene. Human Mutation, 35(4), 486-496. Abstract.
Broenen E, Mavinkurve-Groothuis A, Kamphuis-Van Ulzen K, Brüggemann R, Verweij P, Warris A (2014). Screening of the central nervous system in children with invasive pulmonary aspergillosis. Medical Mycology Case Reports, 4(1), 8-11. Abstract.
Kurvers RAJ, Westra D, van Heijst AF, Walk TLM, Warris A, van de Kar NCAJ (2014). Severe infantile Bordetella pertussis pneumonia in monozygotic twins with a congenital C3 deficiency. European Journal of Pediatrics, 173(12), 1591-1594. Abstract.
Schatorjé EJH, Gathmann B, Van Hout RWNM, De Vries E, Alsina L, Baumann U, Belohradsky BH, Bienemann K, Boardman B, Borte M, et al (2014). The PedPAD study: Boys predominate in the hypogammaglobulinaemia registry of the ESID online database. Clinical and Experimental Immunology, 176(3), 387-393. Abstract.
Warris A (2014). The biology of pulmonary aspergillus infections. Journal of Infection, 69(S1), S36-S41. Abstract.
Driessen GJ, Ijspeert H, Weemaes CMR, Haraldsson A, Trip M, Warris A, Van Der Flier M, Wulffraat N, Verhagen MMM, Taylor MA, et al (2013). Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity. Journal of Allergy and Clinical Immunology, 131(5). Abstract.
Verhagen LM, Luesink M, Warris A, De Groot R, Hermans PWM (2013). Bacterial respiratory pathogens in children with inherited immune and airway disorders: Nasopharyngeal carriage and disease risk. Pediatric Infectious Disease Journal, 32(4), 399-404. Abstract.
Schoenaker MHD, Otten B, Finken MJJ, Michiels E, Van Noesel MM, Loeffen J, Warris A, Noordam C, Weemaes CM (2013). Bloom syndrome: Timely diagnosis before growth hormone therapy is being considered. Tijdschrift voor Kindergeneeskunde, 81(6), 142-148. Abstract.
Schatorjé EJH, van der Steeg H, Stelma F, Hebeda K, Warris A (2013). Borrelia-lymfocytoom. Nederlands tijdschrift voor geneeskunde, 157 Abstract.
Brand HK, Ferwerda G, Preijers F, de Groot R, Neeleman C, Staal FJT, Warris A, Hermans PWM (2013). CD4+ T-cell counts and interleukin-8 and CCL-5 plasma concentrations discriminate disease severity in children with RSV infection. Pediatr Res, 73(2), 187-193. Abstract. Author URL.
Smit M, Smit C, Geerlings S, Gras L, Brinkman K, Hallett TB, de Wolf F (2013). Changes in First-Line cART Regimens and Short-Term Clinical Outcome between 1996 and 2010 in the Netherlands. PLoS ONE, 8(9), e76071-e76071.
Henriet SSV, Jans J, Simonetti E, Kwon-Chung KJ, Rijs AJMM, Hermans PWM, Holland SM, De Jonge MI, Warris A (2013). Chloroquine modulates the fungal immune response in phagocytic cells from patients with chronic granulomatous disease. Journal of Infectious Diseases, 207(12), 1932-1939. Abstract.
Ijspeert H, Warris A, van der Flier M, Reisli I, Keles S, Chishimba S, van Dongen JJM, van Gent DC, Van der Burg M (2013). Clinical Spectrum of LIG4 Deficiency is Broadened with Severe Dysmaturity, Primordial Dwarfism, and Neurological Abnormalities. Human Mutation, 34(12), 1611-1614. Abstract.
Driessen GJ, Dalm VASH, van Hagen PM, Anne Grashoff H, Hartwig NG, van Rossum AMC, Warris A, de Vries E, Barendregt BH, Pico I, et al (2013). Common variable immunodeficiency and idiopathic primary hypogammaglobulinemia: Two different conditions within the same disease spectrum. Haematologica, 98(10), 1617-1623. Abstract.
De Mol M, De Jongste JC, Van Westreenen M, Merkus PJFM, De Vries AHC, Hop WCJ, Warris A, Janssens HM (2013). Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan. Pediatric Pulmonology, 48(8), 789-796. Abstract.
Kinabo GD, van der Ven A, Msuya LJ, Shayo AM, Schimana W, Ndaro A, van Asten HAGH, Dolmans WMV, Warris A, Hermans PWM, et al (2013). Dynamics of nasopharyngeal bacterial colonisation in HIV-exposed young infants in Tanzania. Tropical Medicine and International Health, 18(3), 286-295. Abstract.
Opstelten W, Ruijs WL, Warris A, van Binnendijk RS, Wolfs TFW, Hahné SJM (2013). Er heerst weer mazelen. Nederlands tijdschrift voor geneeskunde, 157 Abstract.
Jans J, Brüggemann RJM, Christdmann V, Verweij PE, Warris A (2013). Favorable outcome of neonatal cerebrospinal fluid shunt-associated Candida meningitis with caspofungin. Antimicrobial Agents and Chemotherapy, 57(5), 2391-2393. Abstract.
Van Helmond LPFM, Maartens IA, Van Pelt-Koops JC, Henriet S, Hopman J, Pelleboer RAA, Warris A (2013). Fever without borders. Tijdschrift voor Kindergeneeskunde, 81(5), 135-137. Abstract.
Henriet S, Verweij PE, Holland SM, Warris A (2013). Invasive fungal infections in patients with chronic granulomatous disease. Advances in Experimental Medicine and Biology, 764, 27-55. Abstract.
Opstelten W, Ruijs WLM, Warris A, Binnendijk RSV, Wolfs TFW, Hahné SJM (2013). Klinische les: the measles are here again. Nederlands Tijdschrift voor Geneeskunde, 157(36). Abstract.
Cohen S, Smit C, Van Rossum AMC, Fraaij PLA, Wolfs TFW, Geelen SPM, Schölvinck EH, Warris A, Scherpbier HJ, Pajkrt D, et al (2013). Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012. AIDS, 27(16), 2567-2575. Abstract.
Schoffelen AF, van Lelyveld SFL, Barth RE, Gras L, de Wolf F, Netea MG, Hoepelman AIM (2013). Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors?. AIDS, 27(7), 1179-1184.
Stol K, Verhaegh SJC, Graamans K, Engel JAM, Sturm PDJ, Melchers WJG, Meis JF, Warris A, Hays JP, Hermans PWM, et al (2013). Microbial profiling does not differentiate between childhood recurrent acute otitis media and chronic otitis media with effusion. International Journal of Pediatric Otorhinolaryngology, 77(4), 488-493. Abstract.
Nooitgedagt JE, Warris A, Liem KD, Van't Hek L, Henriet SS (2013). Pertussis in young infants: a dangerous disease with non-specific signs. Nederlands Tijdschrift voor Geneeskunde, 157(4).
Kinabo GD, Sprengers M, Msuya LJ, Shayo AM, van Asten H, Dolmans WMV, van der Ven AJAM, Warris A (2013). Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy. Pediatr Infect Dis J, 32(1), 39-44. Abstract. Author URL.
Brand HK, Borm G, Hermans P, Warris A (2013). Response to 12-0176. Pediatric Pulmonology, 48(6), 625-626.
Geelen J, Pfundt R, Meijer J, Verheijen FW, van Kuilenburg ABP, Warris A, Marcelis C (2013). Severe phenotype of severe combined immunodeficiency caused by adenosine deaminase deficiency in a patient with a homozygous mutation due to uniparental disomy. J Allergy Clin Immunol, 132(1), 222-223. Author URL.
Verweij PE, Warris A (2013). Update on antifungal resistance in children: Epidemiology and recommendations. Pediatric Infectious Disease Journal, 32(5), 556-557.
Schatorjé EJH, van der Steeg H, Stelma F, Hebeda K, Warris A (2013). [Borrelial lymphocytoma]. Nederlands tijdschrift voor geneeskunde, 157(52). Abstract.
Opstelten W, Ruijs WL, Warris A, van Binnendijk RS, Wolfs TFW, Hahné SJM (2013). [The measles are here again]. Nederlands tijdschrift voor geneeskunde, 157(34). Abstract.
de Groot R, Warris A (2012). 29th ESPID Annual Meeting in the Hague, the Netherlands. Pediatr Infect Dis J, 31(4). Author URL.
Henriet SSV, Verweij PE, Warris A (2012). Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interaction. J Infect Dis, 206(7), 1128-1137. Abstract. Author URL.
Donker AE, Mavinkurve-Groothuis AMC, van Die LE, Verweij PE, Hoogerbrugge PM, Warris A (2012). Favorable outcome of chronic disseminated candidiasis in four pediatric patients with hematological malignancies. Med Mycol, 50(3), 315-319. Abstract. Author URL.
Verhagen LM, Hermans PWM, Warris A, de Groot R, Maes M, Villalba JA, del Nogal B, van den Hof S, Mughini Gras L, van Soolingen D, et al (2012). Helminths and skewed cytokine profiles increase tuberculin skin test positivity in Warao Amerindians. Tuberculosis (Edinb), 92(6), 505-512. Abstract. Author URL.
Verhagen LM, Warris A, Hermans PWM, del Nogal B, de Groot R, de Waard JH (2012). High prevalence of acute respiratory tract infections among Warao Amerindian children in Venezuela in relation to low immunization coverage and chronic malnutrition. Pediatr Infect Dis J, 31(3), 255-262. Abstract. Author URL.
Zwitserloot AM, Mavinkurve-Groothuis AMC, Galama JM, Verweij PE, Hoogerbrugge PM, Warris A (2012). Importance of neutropenia for development of invasive infections at various phases of treatment for hemato-oncological diseases in children. Scand J Infect Dis, 44(5), 355-362. Abstract. Author URL.
Brand HK, de Groot R, Galama JMD, Brouwer ML, Teuwen K, Hermans PWM, Melchers WJG, Warris A (2012). Infection with multiple viruses is not associated with increased disease severity in children with bronchiolitis. Pediatr Pulmonol, 47(4), 393-400. Abstract. Author URL.
Stol K, Diavatopoulos DA, Graamans K, Engel JAM, Melchers WJG, Savelkoul HFJ, Hays JP, Warris A, Hermans PWM (2012). Inflammation in the middle ear of children with recurrent or chronic otitis media is associated with bacterial load. Pediatr Infect Dis J, 31(11), 1128-1134. Abstract. Author URL.
Smeekens SP, Henriet SSV, Gresnigt MS, Joosten LAB, Hermans PWM, Netea MG, Warris A, van de Veerdonk FL (2012). Low interleukin-17A production in response to fungal pathogens in patients with chronic granulomatous disease. J Interferon Cytokine Res, 32(4), 159-168. Abstract. Author URL.
Verhagen LM, López D, Hermans PWM, Warris A, de Groot R, García JF, de Waard JH, Aarnoutse RE (2012). Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations. Trop Med Int Health, 17(12), 1449-1456. Abstract. Author URL.
Verhagen MMM, Last JI, Hogervorst FBL, Smeets DFCM, Roeleveld N, Verheijen F, Catsman-Berrevoets CE, Wulffraat NM, Cobben JM, Hiel J, et al (2012). Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study. Hum Mutat, 33(3), 561-571. Abstract. Author URL.
Steinbach WJ, Roilides E, Berman D, Hoffman JA, Groll AH, Bin-Hussain I, Palazzi DL, Castagnola E, Halasa N, Velegraki A, et al (2012). Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J, 31(12), 1252-1257. Abstract. Author URL.
Brand KH, Ahout IML, de Groot R, Warris A, Ferwerda G, Hermans PWM (2012). Use of MMP-8 and MMP-9 to assess disease severity in children with viral lower respiratory tract infections. J Med Virol, 84(9), 1471-1480. Abstract. Author URL.
Hartwig NG, Warris A, van de Vosse E, van der Zanden AGM, Schülin-Casonato T, van Ingen J, van Hest R (2011). "Mycobacterium tilburgii" infection in two immunocompromised children: importance of molecular tools in culture-negative mycobacterial disease diagnosis. J Clin Microbiol, 49(12), 4409-4411. Abstract. Author URL.
Welzen MEB, Brüggemann RJM, Van Den Berg JM, Voogt HW, Gilissen JH, Pajkrt D, Klein N, Burger DM, Warris A (2011). A novel twice daily posaconazole dosing algorithm for children with chronic granulomatous disease results in adequate exposure. Pharmaceutisch Weekblad, 146(50), 211-214.
Welzen MEB, Brüggemann RJM, Van Den Berg JM, Voogt HW, Gilissen JH, Pajkrt D, Klein N, Burger DM, Warris A (2011). A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease. Pediatr Infect Dis J, 30(9), 794-797. Abstract. Author URL.
Adams NG, Adekambi T, Afeltra J, Aguado J, Aires de Sousa M, Akiyoshi K, Al Hasan M, Ala-Kokko T, Albert M, Alfandari S, et al (2011). ACKNOWLEDGEMENT OF REVIEWERS. Clinical Microbiology and Infection, 17(1), 102-103.
Ijspeert H, Lankester AC, van den Berg JM, Wiegant W, van Zelm MC, Weemaes CMR, Warris A, Pan-Hammarström Q, Pastink A, van Tol MJD, et al (2011). Artemis splice defects cause atypical SCID and can be restored in vitro by an antisense oligonucleotide. Genes Immun, 12(6), 434-444. Abstract. Author URL.
Van Der Linden JWM, Warris A, Verweij PE (2011). Aspergillus species intrinsically resistant to antifungal agents. Med Mycol, 49 Suppl 1, S82-S89. Abstract. Author URL.
Driessen GJ, van Zelm MC, van Hagen PM, Hartwig NG, Trip M, Warris A, de Vries E, Barendregt BH, Pico I, Hop W, et al (2011). B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency. Blood, 118(26), 6814-6823. Abstract. Author URL.
Henriet SSV, Hermans PWM, Verweij PE, Simonetti E, Holland SM, Sugui JA, Kwon-Chung KJ, Warris A (2011). Human leukocytes kill Aspergillus nidulans by reactive oxygen species-independent mechanisms. Infect Immun, 79(2), 767-773. Abstract. Author URL.
Brüggemann RJM, van der Linden JWM, Verweij PE, Burger DM, Warris A (2011). Impact of therapeutic drug monitoring of voriconazole in a pediatric population. Pediatr Infect Dis J, 30(6), 533-534. Abstract. Author URL.
Lutsar I, Trafojer UMT, Heath PT, Metsvaht T, Standing J, Esposito S, de Cabre VM, Oeser C, Aboulker J-P (2011). Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial. Trials, 12(1).
Delsing CE, Warris A, Bleeker-Rovers CP (2011). Q fever: still more queries than answers. Adv Exp Med Biol, 719, 133-143. Abstract. Author URL.
van de Glind GJ, Gidding CEM, Verlaat CMW, Duthoi K, Backx APC, Verweij PE, Warris A (2010). Acute Cardiac Failure due to Intra-Atrial Mass Caused by Zygomycetes in an Immunocompromised Paediatric Patient. Case Rep Med, 2010 Abstract. Author URL.
Chai LYA, Netea MG, Sugui J, Vonk AG, van de Sande WWJ, Warris A, Kwon-Chung KJ, Kullberg BJ (2010). Aspergillus fumigatus conidial melanin modulates host cytokine response. Immunobiology, 215(11), 915-920. Abstract. Author URL.
Verhagen LM, Warris A, van Soolingen D, de Groot R, Hermans PWM (2010). Human immunodeficiency virus and tuberculosis coinfection in children: challenges in diagnosis and treatment. Pediatr Infect Dis J, 29(10), e63-e70. Abstract. Author URL.
Damen GM, van Krieken JH, Hoppenreijs E, van Os E, Tolboom JJM, Warris A, Yntema J-B, Nieuwenhuis EES, Escher JC (2010). Overlap, common features, and essential differences in pediatric granulomatous inflammatory bowel disease. J Pediatr Gastroenterol Nutr, 51(6), 690-697. Abstract. Author URL.
Warris A, Onken A, Gaustad P, Janssen W, van der Lee H, Verweij PE, Abrahamsen TG (2010). Point-of-use filtration method for the prevention of fungal contamination of hospital water. J Hosp Infect, 76(1), 56-59. Abstract. Author URL.
Smyth AR, Barbato A, Beydon N, Bisgaard H, de Boeck K, Brand P, Bush A, Fauroux B, de Jongste J, Korppi M, et al (2010). Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J, 35(2), 247-265. Abstract. Author URL.
Boer K, Smit C, van der Flier M, de Wolf F (2010). The comparison of the performance of two screening strategies identifying newly-diagnosed HIV during pregnancy. The European Journal of Public Health, 21(5), 632-637.
Noordzij JG, Wulffraat NM, Haraldsson A, Meyts I, van't Veer LJ, Hogervorst FBL, Warris A, Weemaes CMR (2009). Ataxia-telangiectasia patients presenting with hyper-IgM syndrome. Arch Dis Child, 94(6), 448-449. Abstract. Author URL.
Van Der Linden JW, Warris A, Van Der Meer JW, Bresters D, Melchers WJ, Verweij PE (2009). Azole resistant invasive aspergillosis. Nederlands Tijdschrift voor Geneeskunde, 153(51), 2482-2488.
Chai LYA, Kullberg BJ, Vonk AG, Warris A, Cambi A, Latgé J-P, Joosten LAB, van der Meer JWM, Netea MG (2009). Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. Infect Immun, 77(5), 2184-2192. Abstract. Author URL.
van Raam BJ, van Bruggen R, Tool ATJ, Jansen MH, Warris A, Jolles S, Kuijpers TW (2009). Nuclear factor-{kappa}B is not essential for NADPH oxidase activity in neutrophils from anhidrotic ectodermal dysplasia patients. Blood, 113(21), 5362-5363. Author URL.
Zhang X, Pang Q (2009). Response: Homing defect in hematopoietic cells from Fanconi anemia patients. Blood, 113(21), 5362-5362.
Mocroft A, Sterne JAC, Egger M, May M, Grabar S, Furrer H, Sabin C, Fatkenheuer G, Justice A, Reiss P, et al (2009). Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not all AIDS-Defining Conditions Are Created Equal. Clinical Infectious Diseases, 48(8), 1138-1151. Abstract.
van der Linden JW, Warris A, van der Meer JW, Bresters D, Melchers WJ, Verweij PE (2009). [Azole-resistant invasive aspergillosis]. Ned Tijdschr Geneeskd, 153 Abstract. Author URL.
Verweij PE, Varga J, Houbraken J, Rijs AJMM, VerduynLunel FM, Blijlevens NMA, Shea YR, Holland SM, Warris A, Melchers WJG, et al (2008). <i>Emericella quadrilineata</i> as cause of invasive aspergillosis. EMERGING INFECTIOUS DISEASES, 14(4), 566-572. Author URL.
Kroft EBM, Melchers WJG, Blokx WAM, de Hoop D, Warris A (2008). A generalized skin eruption in a human immunodeficiency virus-infected boy. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 22(7), 896-897. Author URL.
Groeneveld S, Verweij PE, Van't Hek L, Bokkerink JPM, Warris A (2008). Amphotericin B-deoxycholate overdose due to administration error in pediatric patients. MEDICAL MYCOLOGY, 46(2), 185-187. Author URL.
D'Hauw A, Seyger MMB, Groenen PJTA, Weemaes CMR, Warris A, Blokx WAM (2008). Cutaneous graft-versus-host-like histology in childhood. Importance of clonality analysis in differential diagnosis. A case report. BRITISH JOURNAL OF DERMATOLOGY, 158(5), 1153-1156. Author URL.
Zwitserloot AM, Warris A, van't Hek LG, van Die LE, Verweij PE, Mavinkurve-Groothuis AMC (2008). Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia. PEDIATRIC BLOOD & CANCER, 51(3), 423-426. Author URL.
(2008). Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?. AIDS, 22(18), 2481-2492.
Dekkers R, Verweij PE, Weemaes CMR, Severijnen RSVM, Van Krieken JHJM, Warris A (2008). Gastrointestinal zygomycosis due to <i>Rhizopus microsporus</i> var. <i>rhizopodiformis</i> as a manifestation of chronic granulomatous disease. MEDICAL MYCOLOGY, 46(5), 491-494. Author URL.
de Jager M, Blokx W, Warris A, Bergers M, Link M, Weemaes C, Seyger M (2008). Immunohistochemical features of cutaneous granulomas in primary immunodeficiency disorders: a comparison with cutaneous sarcoidosis. JOURNAL OF CUTANEOUS PATHOLOGY, 35(5), 467-472. Author URL.
Mennink-Kersten MASH, Ruegebrink D, Klont RR, Warris A, Blijlevens NAA, Donnelly JP, Verweij PE (2008). Improved detection of circulating <i>Aspergillus</i> antigen by use of a modified pretreatment procedure. JOURNAL OF CLINICAL MICROBIOLOGY, 46(4), 1391-1397. Author URL.
Verweij PE, Van Der Velden WJFM, Blijlevens NMA, Donnelly JP, Warris A (2008). Invasive zygomycosis in patients treated for haematological malignancies. Nederlands Tijdschrift voor Geneeskunde, 152(5).
Bruggemann RJM, Donnelly JP, Aarnoutse RE, Warris A, Blijlevens NMA, Mouton JW, Verweij PE, Burger DM (2008). Therapeutic drug monitoring of voriconazole. THERAPEUTIC DRUG MONITORING, 30(4), 403-411. Author URL.
Brüggemann RJM, Antonius T, Heijst AV, Hoogerbrugge PM, Burger DM, Warris A (2008). Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation. Ther Drug Monit, 30(6), 643-646. Abstract. Author URL.
Lʼhomme R, Warris A, Gibb D, Burger D (2007). Children with HIV are not small adults: what is different in pharmacology?. Curr Opin HIV AIDS, 2(5), 405-409. Abstract. Author URL.
Ament AJH, Hubben MWA, Verweij PE, de Groot R, Warris A, Donnelly JP, 't Wout JV, Severens JL (2007). Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 60(2), 385-393. Author URL.
Raaijmakers R, Schroder C, Monnens L, Cornelissen E, Warris A (2007). Fungal peritonitis in children on peritoneal dialysis. PEDIATRIC NEPHROLOGY, 22(2), 288-293. Author URL.
L'homme RFA, Dijkema T, Warris A, van der Ven AJAM, Gibb DM, Burger DM (2007). Pharmacokinetics of two generic fixed-dose combinations for HIV-infected children (Pedimune Baby & Pedimune Junior) are similar to the branded products in healthy adults. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 59(1), 92-96. Author URL.
Verweel G, Burger DM, Sheehan NL, Bergshoeff AS, Warris A, van der Knaap LC, Driessen G, de Groot R, Hartwig NG (2007). Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and below. ANTIVIRAL THERAPY, 12(4), 453-458. Author URL.
Winn RM, Warris A, Gaustad P, Abrahamsen TG (2007). The effect of antifungal agents and human monocytes on <i>in vitro</i> galactomannan release by <i>Aspergillus</i> spp. in liquid culture medium. APMIS, 115(12), 1364-1369. Author URL.
Verweij PE, van der Velden WJFM, Donnelly JP, Blijlevens NMA, Warris A (2007). [Invasive zygomycosis in patients treated for haematological malignancies]. Ned Tijdschr Geneeskd, 151(47), 2597-2602. Abstract. Author URL.
Mennink-Kersten MASH, Warris A, Verweij PE (2006). 1,3-β-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid. NEW ENGLAND JOURNAL OF MEDICINE, 354(26), 2834-2835. Author URL.
Raaijmakers R, Monnens LAH, Warris A, Schroeder CH (2006). Intestinal perforations in children on peritoneal dialysis. PERITONEAL DIALYSIS INTERNATIONAL, 26(6), 712-714. Author URL.
van der Meer W, Stephen Scott C, Verlaat C, Gunnewiek JK, Warris A (2006). Measurement of neutrophil membrane CD64 and HLA-Dr in a patient with abdominal sepsis. J Infect, 53(1), e43-e46. Abstract. Author URL.
Wortmann SB, Fiselier TJW, Van de Kar NCAJ, Aarts RAHM, Warris A, Draaisma JMT (2006). Refractory severe intestinal vasculitis due to Henoch-Schonlein Purpura: Successful treatment with plasmapheresis. ACTA PAEDIATRICA, 95(5), 622-623. Author URL.
De Mol AC, Vrancken S, Eggink AJ, Verduyn Lunel FM, Warris A (2006). Rubella epidemic in the Netherlands in 2004/'05: First newborn with congenital rubella syndrome. Nederlands Tijdschrift voor Geneeskunde, 150(13), 741-746. Abstract.
De Mol AC, Vrancken S, Eggink AJ, Verduyn Lunel FM, Warris A (2006). Rubella epidemic in the Netherlands in 2004/'05: First newborn with congenital rubella syndrome [9]. Nederlands Tijdschrift voor Geneeskunde, 150(24).
Warris A, Draaisma JMT (2006). Tuberculosis in the Netherlands. Tijdschrift voor Kindergeneeskunde, 74(1), 21-22.
de Mol AC, Vrancken S, Eggink AJ, Verduyn Lunel FM, Warris A (2006). [The first newborn with congenital rubella syndrome during the rubella epidemic in the Netherlands in 2004/'05]. Ned Tijdschr Geneeskd, 150(13), 741-746. Abstract. Author URL.
Mennink-Kersten MASH, Ruegebrink D, Klont RR, Warris A, Gavini F, Op den Camp HJM, Verweij PE (2005). Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J Clin Microbiol, 43(8), 3925-3931. Abstract. Author URL.
Warris A, Netea MG, Verweij PE, Gaustad P, Kullberg BJ, Weemaes CMR, Abrahamsen TG (2005). Cytokine responses and regulation of interferon-gamma release by human mononuclear cells to <i>Aspergillus fumigatus</i> and other filamentous fungi. MEDICAL MYCOLOGY, 43(7), 613-621. Author URL.
Overland G, Stuestol JF, Dahle MK, Myhre AE, Netea MG, Verweij P, Yndestad A, Aukrust P, Kullberg BJ, Warris A, et al (2005). Cytokine responses to fungal pathogens in Kupffer cells are Toll-like receptor 4 independent and mediated by tyrosine kinases. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 62(2), 148-154. Author URL.
Bleeker-Rovers CP, Warris A, Drenth JPH, Corstens FHM, Oyen WJG, Kullberg BJ (2005). Diagnosis of <i>Candida</i> lung abscesses by <SUP>18</SUP>F-fluorodeoxyglucose positron emission tomography. CLINICAL MICROBIOLOGY AND INFECTION, 11(6), 493-495. Author URL.
Caseldine C, Russell A, Hardardóttir J, Knudsen O (2005). Preface. Developments in Quaternary Science, 5(C).
Kroft EBM, Warris A, Jansen LE, van Crevel R (2005). [A Dutchman from Mali with a perianal ulcer caused by cutaneous amoebiasis]. Ned Tijdschr Geneeskd, 149(6), 308-311. Abstract. Author URL.
Den Hollander JG, De Vries-Sluijs TEMS, Warris A, Schneider AJ, Hartwig NG, Van Der Ende ME (2004). A test forgotten, a sentence for life. Nederlands Tijdschrift voor Obstetrie en Gynaecologie, 117(4), 112-115. Abstract.
Mennink-Kersten MASH, Klont RR, Warris A, Op den Camp HJM, Verweij PE (2004). Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection. Lancet, 363(9405), 325-327. Abstract. Author URL.
Netea MG, Warris A, Van der Meer JWM, Fenton MJ, Verver-Janssen TJG, Jacobs LEH, Andresen T, Verweij PE, Kullberg BJ (2003). Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis, 188(2), 320-326. Abstract. Author URL.
Warris A, Netea MG, Wang JE, Gaustad P, Kullberg B-J, Verweij PE, Abrahamsen TG (2003). Cytokine release in healthy donors and patients with chronic granulomatous disease upon stimulation with Aspergillus fumigatus. Scand J Infect Dis, 35(8), 482-487. Abstract. Author URL.
Warris A, Klaassen CHW, Meis JFGM, De Ruiter MT, De Valk HA, Abrahamsen TG, Gaustad P, Verweij PE (2003). Molecular epidemiology of Aspergillus fumigatus isolates recovered from water, air, and patients shows two clusters of genetically distinct strains. J Clin Microbiol, 41(9), 4101-4106. Abstract. Author URL.
Berger VW, Franzblau MJ, Verweij PE, Warris A, Weemaes CM, Gallin JI, Wesley R, Holland SM (2003). Preventing fungal infections in chronic granulomatous disease [5] (multiple letters). New England Journal of Medicine, 349(12), 1190-1191.
Verweij PE, Warris A, Weemaes CM (2003). Preventing fungal infections in chronic granulomatous disease. N Engl J Med, 349(12), 1190-1191. Author URL.
Warris A, Voss A, Abrahamsen TG, Verweij PE (2002). Contamination of hospital water with Aspergillus fumigatus and other molds. Clin Infect Dis, 34(8), 1159-1160. Author URL.
Warris A, Weemaes CM, Verweij PE (2002). Multidrug resistance in Aspergillus fumigatus. N Engl J Med, 347(26), 2173-2174. Author URL.
Warris A, Semmekrot BA, Voss A (2001). Candidal and bacterial bloodstream infections in premature neonates: a case-control study. Medical Mycology, 39(1), 75-79. Abstract.
Warris A, Semmekrot BA, Voss A (2001). Candidal and bacterial bloodstream infections in premature neonates: a case-control study. Med Mycol, 39(1), 75-79. Abstract. Author URL.
Warris A, Voss A, Verweij PE (2001). Hospital sources of Aspergillus: New routes of transmission?. Rev Iberoam Micol, 18(4), 156-162. Abstract. Author URL.
Warris A, Bjørneklett A, Gaustad P (2001). Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med, 344(14), 1099-1100. Author URL.
Wang JE, Warris A, Ellingsen EA, Jørgensen PF, Flo TH, Espevik T, Solberg R, Verweij PE, Aasen AO (2001). Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect Immun, 69(4), 2402-2406. Abstract. Author URL.
Warris A, Gaustad P, Meis JF, Voss A, Verweij PE, Abrahamsen TG (2001). Recovery of filamentous fungi from water in a paediatric bone marrow transplantation unit. J Hosp Infect, 47(2), 143-148. Abstract. Author URL.
Warris A, Wesenberg F, Gaustad P, Verweij PE, Abrahamsen TG (2000). Acremonium strictum fungaemia in a paediatric patient with acute leukaemia. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 32(4), 442-444. Author URL.
Warris A, Verweij PE, Barton R, Crabbe DC, Evans EG, Meis JF (1999). Invasive aspergillosis in two patients with Pearson syndrome. Pediatr Infect Dis J, 18(8), 739-741. Author URL.
Chapters
Warris A, Kroon FP (2017). 9 Viral Exanthems. In (Ed) Infectious Diseases, Elsevier, 75-83.e1.
Warris A, Kroon FP (2017). Viral Exanthems. In (Ed) Infectious Diseases, 2-Volume Set, 75-83.e1.
Henriet S, Verweij PE, Holland SM, Warris A (2013). Invasive Fungal Infections in Patients with Chronic Granulomatous Disease. In (Ed) HOT TOPICS IN INFECTION AND IMMUNITY IN CHILDREN IX, 27-55. Author URL.
Warris A, Kroon FP (2010). Chapter 8 Viral exanthems. In (Ed) Infectious Diseases, Elsevier, 99-108.
Warris A, Kroon FP (2010). Viral exanthems. In (Ed) Infectious Diseases: Third Edition, 99-108.
Mahdi KA (2001). Introduction. In Mahdi KA (Ed) Water in the Arabian Peninsula: Problems and Policies, Ithaca Press, 1-15.
Conferences
Ottaviano G, Nademi Z, Campbell H, Mottram R, James B, Tatarinova O, Furness C, Patrick K, Ochaya O, Lawson S, et al (2022). Incidence of invasive fungal disease and risk factors in 368 children receiving allogeneic haematopoietic cell transplantation: a UK multi-centre, prospective audit on national anti-fungal guidelines. Author URL.
Groll AH, Averbuch D, Castagnola E, Cesaro S, Engelhard D, Garcia-Vidal C, Lanternier F, Messini A, Pana D, Ritz N, et al (2020). Highlights of ECIL: Recommendations in Invasive Fungal Disease in Children. Author URL.
Lehrnbecher T, Averbuch D, Castagnola E, Cesaro S, Garcia-Vidal C, Lanternier F, Messini A, Mikulska M, Pana D, Ritz N, et al (2020). Highlights of ECIL: Recommendations in Pediatric Febrile Neutropenia. Author URL.
Warris A (2018). Defective antifungal immunity in cystic fibrosis. Author URL.
Turner S, Warris A, an S-Q (2018). Microbiome Characteristics of Induced Sputum compared to Bronchial Fluid and Upper Airway Samples. Author URL.
Bastiaans D, Immohr I, Zeinstra G, Bartels-Wilmer C, Smeets O, Von der Flier M, Strik-Albers R, Pein M, Colbers A, Burger D, et al (2018). The VALID-project: Development of a new paediatric formulation of valaciclovir. Author URL.
Ballard E, Weber J, Brakhage AA, Zoll J, Melchers WJG, Brown AJP, Verweij PE, Warris A (2018). Using CRISPR/Cas9 to unravel the complex role of single nucleotide substitutions in Aspergillus fumigatus in-host adaptation. Author URL.
Lehrnbecher T, Warris A (2017). Antifungal prophylaxis in immunocompromised children. Author URL.
Bercusson A, De Boer L, Warris A, Armstrong-James D (2017). CFTR REGULATES NORMAL MACROPHAGE RESPONSES TO <i>ASPERGILLUS FUMIGATUS</i>. Author URL.
Westra D, Kurvers RAJ, van den Heuvel LP, Wurzner R, van de Karl NCA, Warris A (2013). Compound heterozygous mutations in the C6-gene in a child with relapsing bacterial and viral infections. Author URL.
van Jaarsveld P, Gordijn S, Gemke RJB, Kaspers GJL, de Goffau A, van Esch J, de Vries E, Warris A, Driessen GJ (2012). FATIGUE IN CHILDREN WITH PRIMARY ANTIBODY DEFICIENCY. Author URL.
IJspeert H, Warris A, van Flier M, Chishimba S, van Dongen JJM, van Gent DC, van der Burg M (2012). LIGASE-4 DEFICIENT PATIENT WITH a NEW VERY SEVERE PHENOTYPE DUE TO C-TERMINALLY TRUNCATING MUTATIONS. Author URL.
Driessen GJ, IJspeert H, Weemaes C, Harraldsson A, Trip M, Warris A, van der Flier M, Wulffraat N, Verhagen MMM, Taylor MM, et al (2012). SEVERITY OF ANTIBODY DEFICIENCY IN ATAXIA TELANGIECTASIA IS ASSOCIATED WITH INTRINSIC DEFECTS IN B- AND T-CELL DEVELOPMENT. Author URL.
de Boer M, van Leeuwen K, Kuijpers TW, Weemaes CM, Warris A, van den Berg TK, Vinckenbosch N, Roos D (2011). Chronic granulomatous disease caused by a partly exonised retroposed <i>TMF1</i> gene copy inserted into the <i>CYBB</i> gene. Author URL.
Warris A (2011). The environment and human mycoses: water. Author URL.
Warris A (2010). FUNGAL INFECTIONS - PREVENTION AND TREATMENT. Author URL.
Henriet SSV, Rijs AJMM, Verweij PE, Hermans PWM, Warris A (2009). Distinctive ROS function induced by <i>Aspergillus</i> <i>nidulans</i> and <i>Aspergillus</i> <i>fumigatus</i> during <i>in vitro</i> phagocytosis by X-CGD monocytes. Author URL.
Kelly A, Weiss M (2009). Preface.
Warris A (2009). Primary immunodeficiencies and fungal infections. Author URL.
Van der Linden JWM, Bruggemann RJM, Knoop J, Verweij PE, Burger DM, Warris A (2009). Therapeutic drug monitoring of voriconazole in pediatric patients. Author URL.
Chai L, Netea M, Vonk A, Warris A, Kutberg BJ (2008). <i>Aspergillus</i> attenuates distinct host TLR2 & TLR4 responses. Author URL.
Noordzij JG, Seyger M, Preijers F, Hoogerbrugge P, de Groot R, van de Vosse E, Lankester AC, van der Burg M, Warris A (2008). Early diagnosis of hypohidrotic ectodermal dysplasia with immune deficiency due to NEMO mutation successfully cured by BMT. Author URL.
IJspeert H, Lankester AC, Weemaes CMR, Warris A, Wiegant W, Van Zelm MC, van Tol MJD, van Gent DC, van Dongen JJM, van der Burg M, et al (2008). New type of SCID due to aberrant Artemis splicing. Author URL.
Klont RR, Noordzij JG, Bot P, Schulin-Casonato T, Warris A (2007). A child with endocarditis due to <i>Enterobacter cloacae</i> responded to long-term antibiotic treatment without cardiac surgery. Author URL.
van de Wetering M, Goossen G, Warris A (2007). Influenza vaccination in children with cancer, a Cochrane systematic review. Author URL.
Klont RR, Rijs AJM, Warris A, Sturm PDJ, Melchers WJG, Verweij PE (2006). <i>Legionella pneumophila</i> in commercial bottled mineral water. Author URL.
Kroft EBM, Warris A, Jansen LE, Van Crevel R, De Hoop D (2005). A Dutchman from Mali with a perianal ulcer caused by cutaneous amoebiasis. Abstract.
Warris A, Verweij PE (2005). Clinical implications of environmental sources for <i>Aspergillus</i>. Author URL.
Overland G, Stuestol JF, Dahle MK, Myhre A, Netea MG, Warris A, Verweij PE, Kullberg BJ, Wang JE, Aasen AO, et al (2005). Innate responses of Kupffer cells to fungal pathogens seems to involve Src tyrosin kinase, but does not involve TLR4. Author URL.
Wang JE, Warris A, Elllingsen EA, Jorgensen PF, Flo TH, Espevik T, Solberg R, Verweij PE, Aasen AO (2001). Involvement of CD14 and toll-like receptors in signalling by <i>Aspergillus</i> hyphae. Author URL.
Gil-Lamaignere C, Warris A, Abrahamsen T, Roilides E (2000). Inhibition of neutrophil oxidative burst by <i>Scedosporium prolificans</i> and <i>Aspergillus fumigatus</i> hyphae. Author URL.
Warris A, Semmekrot B, Voss A (1998). Case-control study of candidemia vs. bacteremia in a neonatal intensive care unit. Author URL.
